Dr Williams-Gray’s team at the University of Cambridge’s Centre for Parkinson-Plus are conducting a clinical trial of azathioprine (AZA-PD), a medication already used to treat inflammation by dampening down the immune system’s response, with the aim of slowing brain cell damage and slowing the progression of Parkinson’s.

Cure Parkinson’s is funding a sub-study of the AZA-PD clinical trial which will examine precisely how azathioprine interacts with the immune system in Parkinson’s.


Find out if you are eligible to take part.

Please note: If you would like to take part in this trial, you will need to be able to travel easily and frequently to Cambridge for trial visits.

How helpful was this content?

/ 5. Vote count:

We are sorry that this content was not useful for you

Let us improve this content

Can you tell us how we can improve this content?